Faster Results, Fewer Bottlenecks: Optimizing Pathology Workflows
Agilent Technologies
Reduce turnaround time, enhance diagnostic accuracy, and minimize manual labor in immunohistochemistry
Stable and compatible with a wide variety of HLA allotypes, pMHC-I molecules are a versatile immunotherapy tool
HMGB3 could effectively label the precancerous cells at different pathological stages